Proactive Investors
04 Aug 2026, 07:09 UTC · 2h ago
Smith & Nephew cuts sales outlook after weak US trading
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Proactive Investors
04 Aug 2026, 07:09 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
Smith & Nephew PLC lowered its full-year revenue growth forecast from approximately 6% to around 4% due to weakness in US orthopaedics and wound care. — A downward revision of growth guidance typically triggers immediate share price depreciation, as seen in the 6.6% tumble.
-0.60The company's underlying revenue growth for the first half was 2.3%, missing the broker consensus forecast of 3.5%. — Missing analyst expectations on top-line growth indicates a deterioration in market share or demand relative to market sentiment.
-0.40Smith & Nephew maintained its guidance for trading profit, free cash flow, and return on invested capital, supported by $200 million in expected total savings for 2026. — Strong cost discipline and maintained profit targets provide a floor for the valuation despite the revenue miss.
+0.30Continue reading
6 related stories
Search tags
The company increased its interim dividend by 4% to 15.6 cents per share. — A dividend increase signals management confidence in cash flow stability despite operational headwinds.
+0.20Which stocks this story touches
The CEO reported accelerated US patent examination for a gene variant, strengthening the company's therapeutic pipeline protection.
Shares tumbled after the company cut its full-year revenue growth forecast due to weakness in US orthopaedics and wound care.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.

Reuters
2h ago